Curemedinova Diagnostic & Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Curemedinova Diagnostic & Pharmacy
Curemedinova Diagnostic & Pharmacy Private Limited (CDPPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 April 2022 (Two years and ten months 14 days old ). Its registered office is in Midnapore, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Subhendu Das, Sujit Sikdar, and Asim Das serve as directors at the Company.
Company Details
- Location
Midnapore, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24290WB2022PTC253022
- Company No.
253022
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2022
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Curemedinova Diagnostic & Pharmacy?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhendu Das  | Managing Director | 13-Apr-2022 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujit Sikdar | Director | 13-Apr-2022 | Current |
| Asim Das | Director | 13-Apr-2022 | Current |
Financial Performance of Curemedinova Diagnostic & Pharmacy.
Enhance accessibility to Curemedinova Diagnostic & Pharmacy's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Curemedinova Diagnostic & Pharmacy?
Unlock access to Curemedinova Diagnostic & Pharmacy's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Curemedinova Diagnostic & Pharmacy?
Curemedinova Diagnostic & Pharmacy has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curemedinova Diagnostic & Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curemedinova Diagnostic & Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.